The Valley Desk

ArticleFuture oncology (London, England)Published

Community hematologist/oncologist perspectives on minimal residual disease testing in patients with multiple myeloma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Future oncology (London, England)
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm, Residual; Female; Male; Surveys and Questionnaires; Practice Patterns, Physicians'; Clinical Decision-Making; Oncologists; Survey; Multiple myeloma; Minimal Residual Disease
PubMed ID
40832984
PubMed Central ID
PMC12439568
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal